Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ciprofloxacin,Celecoxib
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : NeuroSense Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
NeuroSense and Genetika+ Begin Precision Medicine Collaboration in Alzheimer's Disease
Details : The collaboration aims to advance clinical development of PrimeC (ciprofloxacin and celecoxib), currently in mid-stage trials for Alzheimer's disease.
Brand Name : PrimeC
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 22, 2024
Lead Product(s) : Ciprofloxacin,Celecoxib
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : NeuroSense Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?